Welcome to our dedicated page for Innovex International SEC filings (Ticker: INVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Innovex International, Inc. (NYSE: INVX), a Houston-based energy industrial platform operating in the Oil & Gas Equipment & Services industry. Innovex files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with any other required disclosures.
Recent Form 8-K filings referenced by the company include reports of quarterly financial results and other material events. For example, Innovex has filed 8-Ks to furnish earnings press releases for quarters ended March 31, June 30, and September 30, 2025, and to report matters such as the planned sale and subsequent closing of a legacy facility and board-related changes. These filings often incorporate press releases that discuss revenue, net income, cash flow, Adjusted EBITDA, Free Cash Flow, and Return on Capital Employed, along with reconciliations of non-GAAP measures to GAAP metrics.
Through this SEC filings page, users can review Innovex’s 10-K and 10-Q reports for detailed information on its well-centric product portfolio, risk factors, segment performance, and capital allocation approach, as described by the company. Form 4 and other ownership filings, when available, can be used to monitor transactions by directors, officers, and significant shareholders.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, highlight notable changes from prior periods, and clarify technical language. Real-time updates from the SEC’s EDGAR system ensure that new Innovex filings, including earnings-related 8-Ks and other material disclosures, are added promptly so investors can quickly see how the company’s regulatory reporting aligns with its public commentary on strategy, M&A, and financial performance.
Innovex International, Inc. Chief Executive Officer and director Adam Anderson reported an open-market sale of common stock. On February 24, 2026, he sold 18,837 shares of Innovex common stock at $28.50 per share in a transaction classified as a sale in the open market or a private transaction.
The filing states that all shares in this trade were sold at the reported price and that the sales were made pursuant to a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025. After this transaction, Anderson’s directly held Innovex common stock position is 466,744 shares.
Innovex International, Inc. is registering the resale of 5,750,000 shares of its common stock by selling stockholders as set forth in a preliminary prospectus supplement dated February 25, 2026. The Company will receive no proceeds from these sales and has agreed to register up to 29,369,822 shares for resale under the base prospectus.
The prospectus supplement states the Company intends, subject to completion of the offering, to repurchase the lesser of 10% of the offered shares or $15,000,000 (which would equal 575,000 shares if repurchasing 10%). Shares outstanding were 69,138,690 shares as of February 24, 2026. The underwriters have a 30‑day option to purchase additional shares and lock-up and registration‑rights provisions apply to the selling stockholders and certain insiders.
Innovex International, Inc. Chief Executive Officer and director Adam Anderson reported an open-market sale of company stock. On February 23, 2026, he sold 13,241 shares of common stock at $27.00 per share under a pre-arranged Rule 10b5-1 trading plan adopted on March 14, 2025.
After this transaction, Anderson directly owned 485,581 shares of Innovex International common stock. The filing specifies that all shares in this trade were sold at the stated price per share.
Innovex International, Inc. files its annual report describing a larger, more diversified oilfield technology business following a merger and several acquisitions. Legacy Innovex merged with Dril-Quip and the combined company bought majority stakes in Downhole Well Solutions, SCF Machining and Citadel Casing Solutions, adding cash-and-share funded deals across 2024–2025.
The company designs, manufactures, rents and services mission‑critical downhole tools used across the well lifecycle, with 2025 revenue split between North American and International/Offshore markets and weighted toward product sales. Management estimates an $8.0 billion addressable market and mid‑teens share in North America.
Innovex highlights a “No Barriers” culture, in‑house and outsourced manufacturing across several countries, and a large patent portfolio. The report also emphasizes extensive risk factors tied to oil and gas cyclicality, global expansion, regulation, climate and fracturing policies, supply chain, indebtedness, and compliance with trade and anti‑corruption laws.
INVX disclosure: A Rule 144 notice reports 18,837 common shares to be sold by the reporting person tied to a 01/01/2024 stock award. The filing lists prior permitted sales of 13,241 shares on 01/14/2026 for $331,025.00 and 13,241 shares on 02/23/2026 for $357,507.00. The securities are listed on NYSE and the covering notice is dated 02/24/2026.
Innovex International, Inc. reported strong fourth-quarter and full-year 2025 results, highlighted by Q4 revenue of $273,602,000, up 14% sequentially. Q4 net income was $13,968,000 with a 5% net margin, and Adjusted EBITDA reached $52,108,000 with a 19% margin.
For full-year 2025, revenue grew to $978,251,000 and income from operations was $132,625,000. The company generated Q4 Free Cash Flow of $43,311,000 and $155,780,000 for the year, ending 2025 with $203,407,000 in cash and cash equivalents and no bank debt. Management guided Q1 2026 revenue to $225,000,000–$235,000,000 and Adjusted EBITDA to $38,000,000–$42,000,000, noting lower subsea deliveries and a plan to improve subsea margins after exiting the Eldridge facility by the end of Q2 2026.
Issuer: INVX (NYSE) notice of proposed sale under Rule 144 involving common stock tied to a prior stock award.
Broker is UBS Financial Services, Inc.. The filing shows Adam Anderson reported sales of 331,025 common shares on 01/14/2026, and the securities originate from a stock award dated 12/31/2016.
Innovex International, Inc. executive Mark Reddout, President of North America, reported selling 20,000 shares of common stock on January 14, 2026 at $25 per share. The sale was made pursuant to a Rule 10b5-1 trading plan adopted on March 10, 2025, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). After this transaction, he directly beneficially owned 129,436 shares of Innovex International common stock.
Innovex International, Inc. (INVX) Chief Executive Officer and director Adam Anderson reported selling 13,241 shares of common stock on January 14, 2026. The sale, coded as an open market sale, was executed at a price of $25 per share and was carried out under a Rule 10b5-1 trading plan adopted on March 14, 2025, which is designed to pre-arrange trades. Following this transaction, Anderson directly beneficially owns 498,822 shares of Innovex common stock.
An affiliate of INVX has filed a Form 144 giving notice of a planned sale of 20,000 shares of common stock through UBS Financial Services, Inc. on the NYSE. The filing lists an aggregate market value of $500,000 for these shares, compared with 68,927,791 shares outstanding for the issuer.
The shares to be sold were acquired as a stock award from the issuer on July 3, 2024, in a non-cash transaction described as “N/A” for payment. The approximate date of sale is indicated as January 14, 2026. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.